Cellular Therapy

Cellular therapy represents a rapidly evolving field in hematology, focusing on the use of living cells to treat hematologic malignancies and non-malignant blood disorders. These therapies involve modifying or utilizing immune or stem cells to restore normal hematopoiesis or target diseased cells. Cellular therapy has transformed outcomes for patients with refractory or relapsed diseases who previously had limited treatment options. Clinical applications require highly specialized infrastructure, rigorous quality control, and multidisciplinary collaboration. Patient selection, toxicity management, and long-term follow-up are essential components of successful therapy. Ongoing research aims to improve efficacy, reduce adverse effects, and expand indications to earlier disease stages and broader patient populations. Advances in manufacturing processes and regulatory frameworks are helping to increase accessibility. Cellular therapy continues to reshape modern hematology by bridging translational research and clinical care.